SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
SEC Accession No. 0001193125-22-140534
Filing Date
2022-05-04
Accepted
2022-05-04 16:36:15
Documents
1
Group Members
ARIX BIOSCIENCE HOLDINGS LTD

Document Format Files

Seq Description Document Type Size
1 SC 13D/A d357797dsc13da.htm SC 13D/A 54806
  Complete submission text file 0001193125-22-140534.txt   56309
Mailing Address 65 HAYDEN AVE 2ND FLOOR LEXINGTON MA 02421
Business Address 65 HAYDEN AVE 2ND FLOOR LEXINGTON MA 02421 617-245-0399
LogicBio Therapeutics, Inc. (Subject) CIK: 0001664106 (see all company filings)

IRS No.: 471514975 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-90696 | Film No.: 22892095
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address 20 BERKELEY SQUARE LONDON X0 W1J 6EQ
Business Address 20 BERKELEY SQUARE LONDON X0 W1J 6EQ 44(0)20 7290 1050
Arix Bioscience plc (Filed by) CIK: 0001700449 (see all company filings)

IRS No.: 000000000 | State of Incorp.: X0
Type: SC 13D/A